|
|
 |
|
Viewing report
|
|
|
Accentia Biopharmaceuticals Inc (30-Nov-2010)
Directors Deals Ltd, Nov 2010, Pages: 1
Francis Odonnell, (Executive) Chairman & Chief Executive Officer of Accentia Biopharmaceuticals Inc [market cap £34million] bought 225,954 shares at 0.990USD, holding is now 1,388,846 shares; representing 2.393 percent of the shares on issue. Holding has increased 19 percent, the total trade value was £140,644 and the significance rating is 73/100.
Directors Deals monitors and analyses share transactions made by directors in the shares of their own company. We monitor 18,000 companies share transactions in 46 countries worldwide (32 in Europe, 7 in Asia, 2 in North America, 2 in Oceania, 2 in the Middle East & 2 in Africa).
|
|
|
|
